Skip to main content
Philogen logo

Philogen — Investor Relations & Filings

Ticker · PHIL ISIN · IT0005373789 LEI · 81560009EA1577917768 XMIL Manufacturing
Open in API
Filings indexed 377 across all filing types
Latest filing 2025-03-18 Report Publication Anno…
Country IT Italy
Listing XMIL PHIL

About Philogen

https://www.philogen.com

Philogen is a clinical-stage biotechnology company focused on the discovery and development of novel biopharmaceutical products for the treatment of cancer and other serious conditions associated with angiogenesis. Founded in 1996, the company's core strategy is based on innovating targeted therapies, such as antibody-cytokine fusions, which are designed to selectively deliver therapeutic agents to the site of disease. This approach aims to increase efficacy while reducing toxicity. Philogen operates as an integrated company with capabilities in research, GMP manufacturing, and clinical development of its proprietary product pipeline.

Recent filings

Filing Released Lang Actions
Avviso di pubblicazione della documentazione relativa all’Assemblea degli Azionisti convocata per il 29 aprile 2025
Report Publication Announcement Classification · 98% confidence The document is titled "AVVISO DI PUBBLICAZIONE DELLA DOCUMENTAZIONE RELATIVA ALL'ASSEMBLEA DEGLI AZIONISTI CONVOCATA PER IL 29 APRILE 2025" (Notice of Publication of Documentation Relating to the Shareholders' Meeting convened for April 29, 2025). It explicitly states that certain documents (notice of meeting, explanatory report on the appointment of the Board of Directors) are made available to the public. The document itself is short (3265 characters) and serves only to announce the availability of other materials related to an upcoming Shareholders' Meeting. This perfectly matches the definition of a Report Publication Announcement (RPA), as it announces the publication/availability of other reports/materials, rather than being the full AGM materials (AGM-R) or a Proxy Statement (PSI).
2025-03-18 Italian
Relazione illustrativa del Consiglio di Amministrazione sul quarto punto all'ordine del giorno dell'Assemblea degli Azionisti
Proxy Solicitation & Information Statement Classification · 98% confidence The document is titled "RELAZIONE ILLUSTRATIVA DEL CONSIGLIO DI AMMINISTRAZIONE SUL QUARTO PUNTO ALL'ORDINE DEL GIORNO DELL'ASSEMBLEA DEGLI AZIONISTI IN SEDE ORDINARIA, CONVOCATA PER IL 29 APRILE 2025" (Board of Directors' Explanatory Report on the Fourth Item on the Agenda of the Ordinary Shareholders' Meeting, convened for April 29, 2025). The content details the procedures and proposals for the appointment (Nomina) of the Board of Directors, including determining the number of members, term length, and compensation. This document is explicitly a report prepared to inform shareholders ahead of a general meeting regarding specific agenda items, which strongly aligns with the purpose of a Proxy Solicitation & Information Statement (PSI), which solicits votes and provides necessary information for shareholder decisions. While it discusses governance (CGR) and remuneration (DEF 14A), its primary function here is to support the voting process for the AGM regarding board appointments. Since it is a detailed explanatory report for an upcoming shareholder meeting, PSI is the most appropriate classification, as it precedes the actual voting results (DVA) and is more specific than a general Regulatory Filing (RNS). The reference to Article 125-ter of the TUF (Italian Consolidated Financial Act) confirms it is a document related to shareholder meetings.
2025-03-18 Italian
Avviso di convocazione dell'Assemblea Ordinaria e Straordinaria degli Azionisti
AGM Information Classification · 99% confidence The document is titled "AVVISO DI CONVOCAZIONE DI ASSEMBLEA ORDINARIA E STRAORDINARIA" (Notice of Call for Ordinary and Extraordinary Shareholders' Meeting). It details the date, time, and specific agenda items (ORDINE DEL GIORNO) for a shareholders' meeting, including discussions on the 2024 financial statements, board appointments, remuneration policy, and capital structure changes (share issuance, authorization for own share transactions). It also provides extensive instructions on how shareholders can participate and vote exclusively through a Designated Representative, citing specific Italian regulations (TUF articles like 123-ter, 125-quater, 135-undecies.1). This content is characteristic of a formal notice calling for a general meeting, which aligns directly with the definition of AGM Information (AGM-R), as it contains the materials and procedures for the Annual General Meeting.
2025-03-18 Italian
2025 03 17 - CS settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled 'AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE' (Update on the Share Buyback Program) and details the number of own shares purchased by Philogen S.p.A. between March 10 and March 14, 2025, including daily transaction logs. This activity directly corresponds to the definition of a company reporting transactions in its own shares. Reviewing the filing definitions: - 10-K/AR/IR are comprehensive financial reports, which this is not. - ER/MDA are earnings-related. - The core subject is the company buying back its own stock. - Definition 29: Transaction in Own Shares (Code: POS) - Report of the company buying back or selling its own shares (share repurchase/issuance). This document is a specific report detailing share repurchases, making 'POS' the most accurate classification.
2025-03-17 Italian
2025 03 10 - CS settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between March 3 and March 7, 2025, including daily transaction logs. This activity directly relates to the company managing its own outstanding shares through repurchase. According to the definitions, the category 'Transaction in Own Shares' (Code: POS) covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. The document is a detailed report of these transactions, not just a brief announcement of a plan or a general regulatory filing.
2025-03-10 Italian
2025 03 03 - CS settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document title is "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program). The text explicitly details the number of shares purchased, the period of purchase (February 24 to February 28, 2025), average prices, and total consideration. This directly corresponds to the definition of a company reporting transactions involving its own shares. Reviewing the filing types: - 10-K/IR: Incorrect, this is not a full annual or interim financial report. - ER/MDA: Incorrect, this is not an earnings release or management discussion. - DIV: Incorrect, this is about share repurchase, not dividends. - The most fitting category is 'Transaction in Own Shares' (Code: POS), which covers share repurchase programs.
2025-03-03 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.